MedPath
NMPA Approval

Dexrazoxane for Injection

国药准字H20223884

November 30, 2022

Drug Information

注射用右雷佐生

注射剂

250mg

化学药品

November 30, 2022

Company Information

Applicant Company

南京经济技术开发区惠欧路9号

Manufacturing Company

南京经济技术开发区恒广路99号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用右雷佐生 - NMPA 批准文号 | MedPath